| Q33738007 | A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice |
| Q36945212 | A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection |
| Q35532044 | Acute virulence in mice is associated with markers on chromosome VIII in Toxoplasma gondii |
| Q36367127 | Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii |
| Q34955749 | CD73-generated adenosine is critical for immune regulation during Toxoplasma gondii infection |
| Q35038836 | CD8 T Cells and Toxoplasma gondii: A New Paradigm |
| Q38461484 | CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection. |
| Q37041277 | Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication |
| Q64118491 | Comprehensive Kinetic Survey of Intestinal, Extra-Intestinal and Systemic Sequelae of Murine Ileitis Following Peroral Low-Dose Infection |
| Q34002934 | DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice |
| Q53720151 | Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. |
| Q35474667 | Different roles for interleukin-4 during the course of Toxoplasma gondii infection |
| Q71739875 | Dynamics of the intracerebral and splenic cytokine mRNA production in Toxoplasma gondii-resistant and -susceptible congenic strains of mice |
| Q36843269 | Evaluation of Immunoprotection Conferred by the Subunit Vaccines of GRA2 and GRA5 against Acute Toxoplasmosis in BALB/c Mice |
| Q50884140 | Evaluation of the Protective Effect of Deoxyribonucleic Acid Vaccines Encoding Granule Antigen 2 and 5 Against Acute Toxoplasmosis in BALB/c Mice. |
| Q33946644 | Experimental ocular toxoplasmosis in genetically susceptible and resistant mice |
| Q35558303 | Gamma interferon induces Fas-dependent apoptosis of Peyer's patch T cells in mice following peroral infection with Toxoplasma gondii. |
| Q37364789 | Heme oxygenase-1 activity is involved in the control of Toxoplasma gondii infection in the lung of BALB/c and C57BL/6 and in the small intestine of C57BL/6 mice. |
| Q34530251 | Impairment of the cellular immune response in acute murine toxoplasmosis: regulation of interleukin 2 production and macrophage-mediated inhibitory effects. |
| Q33570901 | Intestinal, extra-intestinal and systemic sequelae of Toxoplasma gondii induced acute ileitis in mice harboring a human gut microbiota |
| Q37451015 | Long-term immunity to lethal acute or chronic type II Toxoplasma gondii infection is effectively induced in genetically susceptible C57BL/6 mice by immunization with an attenuated type I vaccine strain |
| Q37577380 | Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly |
| Q27314835 | Nucleotide-oligomerization-domain-2 affects commensal gut microbiota composition and intracerebral immunopathology in acute Toxoplasma gondii induced murine ileitis |
| Q36931850 | Oral oocyst-induced mouse model of toxoplasmosis: effect of infection with Toxoplasma gondii strains of different genotypes, dose, and mouse strains (transgenic, out-bred, in-bred) on pathogenesis and mortality |
| Q55548585 | Peroral Low-Dose Toxoplasma gondii Infection of Human Microbiota-Associated Mice — A Subacute Ileitis Model to Unravel Pathogen–Host Interactions. |
| Q35521010 | Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis |
| Q36826878 | Replication and distribution of Toxoplasma gondii in the small intestine after oral infection with tissue cysts |
| Q36374668 | Role of cytokines and major histocompatibility complex restriction in mouse resistance to infection with a natural recombinant strain (type I-III) of Toxoplasma gondii |
| Q34000936 | Role of gamma interferon in cellular immune response against murine Encephalitozoon cuniculi infection. |
| Q37289969 | Sequential analysis of cell differentials and IFN-gamma production of splenocytes from mice infected with Toxoplasma gondii |
| Q33598817 | Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection in mice |
| Q99710987 | T. gondii infection induces IL-1R dependent chronic cachexia and perivascular fibrosis in the liver and skeletal muscle |
| Q33732215 | The CD8 T-cell road to immunotherapy of toxoplasmosis |
| Q33890472 | The development and biology of bradyzoites of Toxoplasma gondii |
| Q35771619 | Toxoplasma encephalitis in congenic B10 and BALB mice: impact of genetic factors on the immune response. |
| Q36363672 | Toxoplasma gondii possesses a superantigen activity that selectively expands murine T cell receptor V beta 5-bearing CD8+ lymphocytes |
| Q36911407 | Toxoplasma gondii rhoptry 16 kinase promotes host resistance to oral infection and intestinal inflammation only in the context of the dense granule protein GRA15. |
| Q59135889 | Transcriptomic insights into the early host-pathogen interaction of cat intestine with Toxoplasma gondii |
| Q35843444 | Vaccination with Recombinant Microneme Proteins Confers Protection against Experimental Toxoplasmosis in Mice |
| Q30096805 | Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes |